Search results
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Morningstar· 6 days ago(Nasdaq:DRMA)(Nasdaq;DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions ...
Q1 2024 STRATA Skin Sciences Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoThere are over 50 million patients with actually in the US. And the unique and reimbursable underlying sort of nomadic approach with TheraSphere can address limitations of existing active < ...
Should You Avoid Infrared Saunas With Rosacea or Other Skin Conditions?
PopSugar· 7 days agoInfrared saunas are one of the hottest (no pun intended) trends in wellness and beauty right now....
Irritable Bowel Disease cases surging in children & adults, experts studying environmental triggers
CBS News· 2 days agoThis World IBD Day, cases of the incurable diseases have surged across the US, and doctors in...
Critics Say FDA's Use of Surrogate Markers Falling Short
Medscape· 5 days agoAs the FDA's use of surrogate endpoints in the drug approval process is increasing, researchers are...
Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides...
WKRN Nashville· 6 days agoScinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and on providing ...
AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald
ETF DAILY NEWS· 3 days agoCantor Fitzgerald assumed coverage on shares of AbbVie (NYSE:ABBV – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. Cantor Fitzgerald’s price objective ...
Pain-Management Tips Are All Over TikTok. But What’s Legit?
Washingtonian· 6 days agoDoctors share their insights on trending advice on TikTok.
Zacks Research Weighs in on AbbVie Inc.’s FY2024 Earnings (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at Zacks Research raised their FY2024 EPS estimates for AbbVie in a note issued to investors on Tuesday, May 14th. Zacks Research analyst ...
Dermata Therapeutics announces warrant exercise and new issuance By Investing.com
Investing.com· 4 days agoDermata Therapeutics, Inc. (NASDAQ:DRMA), a biotech firm engaged in skin disease treatments, has...
